The news story you are looking for has expired. A more recent related article is displayed below.

Ads by Google

Discovery Labs Could Proceed with Surfaxin Program (DSCO)

9/30/2009 - Discovery Labs (NASDAQ:DSCO) said Wednesday that following talks with the Food and Drug Administration, it may be able to continue with its Surfaxin program. The FDA had delayed the respiratory drug for infants as it requested more information about the drug's shelf life. The company is confident that after the discussion it will be able to move forward, aiming for protocol FDA submission in the fourth quarter. Shares of DSCO moved 32.4% higher during early Wednesday trading.

Write to Chip Brian at cbrian@tradethetrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

Copyright (C) 2009 Comtex SmarTrend(R). All rights reserved

News Provided by COMTEX


Related terms: fda, market, nasdaq, securities

Related Articles

Discovery Labs Submits SURFAXIN Pharmacodynamic Trial Protocol to FDA - Zibb.com
Nov 17, 2009
Discovery Labs Submits SURFAXIN...Nasdaq:DSCO) announced...Food and Drug Administration (FDA) its...RDS). Discovery Labs proposed...that: (a) Discovery Labs and the U.S. Food and Drug Administration (FDA) or...

FDA updates food code
Nov 12, 2009
...Here FDA updates food code The Food and Drug Administration has issued a revised food code that provides...12/2009 12:23:25 PM The Food and Drug Administration has issued a revised food code that provides...

Discovery Labs proposes design for Surfaxin trial
Nov 17, 2009
...Related News Discovery Labs completes stock...offering Discovery Labs responds to approvable letter Discovery Labs-FDA meeting...the Food and Drug Administration. The...Discovery (NASDAQ:DSCO), of Warrington...

Two local life sciences companies recently received U.S. Food and Drug Administration approvals
Nov 4, 2009
...Wednesday, November 4, 2009 at 11:49 a.m. Two local life sciences companies recently received U.S. Food and Drug Administration approvals that clear the way to market products to treat patients. Optima Neuroscience of Alachua received...